Skip to main content
Premium Trial:

Request an Annual Quote

Claremont BioSolutions Moves into Europe, Taiwan, S. Korea with Distribution Deals

NEW YORK (GenomeWeb News) – Molecular diagnostics products firm Claremont BioSolutions has signed deals to distribute its products in Europe, Taiwan, and South Korea.

The deals, announced on Thursday, are with Gentaur Molecular Products, based in Belgium; Ohhana Biotech in Taiwan; and Omics Biotech of South Korea, who will distribute Claremont's products for sample preparation, DNA isolation, and protein purification.

The distributors will sell Claremont's products to the academic, government, and biotech spaces. Financial and other terms of the deals were not disclosed.

Claremont is based in Upland, Calif., and develops and markets cell lysis, DNA and RNA extraction, and His-tagged protein purification kits and columns. In December the company announced distribution deals with Funakoshi covering Japan and with Bioquote covering the UK and Ireland.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.